H. Sawada, S. Orimo, A. Inaba, M. Takahashi. Relationship between cognitive dysfunction and striatal uptake of 123I-FP-CIT in patients with Parkinson's disease. MOVEMENT DISORDERS. 2017. 32
M. Kohsaka, T. Oeda, A. Umemura, S. Tomita, K. Park, K. Yamamoto, H. Sugiyama, H. Sawada. P100 latency of pattern reversal visual evoked potential and visual hallucination in Parkinson's disease. MOVEMENT DISORDERS. 2016. 31. S118-S118
Risk factors for psychosis in Parkinson's disease
(3rd International Symposium on Dopaminergic and Nondopaminergic Mechanisms in Parkinson's Disease 2007)
Cardiac metaiodobenzylguanidine scintigraphy as a peripheral bimarker for the diagnosis of Parkinson's disease
(XVII WFN World Congress on Parkinson's Disease and Related Disorders 2007)
Cardiac metaiodobenzylguanidine (MIBG) scintigraphy as a peripheral bimarker for the diagnosis of Parkinson's disease
(5th Congress of the International Society for Autonomic Neuroscience 2007)
Risk factors for psychosis in Parkinson disease
(17th WFN World Congress on Parkinson’s disease and Related Disorders 2007)